Diabetes has long been recognized as an independent risk factor for cancer, but there is insufficient mechanistic understanding of biological mediators that bridge two disorders together. Understanding the pathogenic association between diabetes and cancer has become the focus of many studies, and findings are potentially valuable for the development of effective preventive or therapeutic strategies for both disorders.
Recent Advances:
A summary of literature reveals a possible connection between diabetes and cancer through the family of protein disulfide isomerase (PDI). Historical as well as the most recent findings on the structure, biochemistry, and biology of the PDI family were summarized in this review.
Critical Issues:
PDIs in general function as redox enzymes and protein chaperones to control the quality of proteins by correcting or otherwise eliminating misfolded proteins in conditions of oxidative stress and endoplasmic reticulum stress, respectively. However, individual members of the PDI family may contribute uniquely to the pathogenesis of diabetes and cancer. Studies of exemplary members such as protein disulfide isomerase-associated (PDIA) 1, PDIA6, and PDIA15 were reviewed to highlight their contributions in the pathogenesis of diabetes and cancer and how they can be potential links bridging the two disorders through the cross talk of signaling pathways.
Future Directions:
Apparently ubiquitous presence of the PDIs creates difficulties and challenges for scientific community to develop targeted therapeutics for the treatment of diabetes and cancer simultaneously. Understanding molecular contribution of individual PDI in the context of specific disease may provide some insights into the development of mechanism-based target-directed therapeutics. Antioxid. Redox Signal. 37, 1191–1205.
Get full access to this article
View all access options for this article.
References
1.
Aguilar-HernandezN, MeyerL, LopezS, et al.Protein disulfide isomerase A4 is involved in genome uncoating during human astrovirus cell entry. Viruses, 2020; 13(1):53; doi: 10.3390/v13010053
2.
Al-FadhliFM, AfqiM, SairafiMH, et al.Biallelic loss of function variant in the unfolded protein response gene PDIA6 is associated with asphyxiating thoracic dystrophy and neonatal-onset diabetes. Clin Genet, 2021; 99(5):694–703; doi: 10.1111/cge.13930
3.
AlbertiA, KaramessinisP, PeroulisM, et al.ERp46 is reduced by high glucose and regulates insulin content in pancreatic beta-cells. Am J Physiol Endocrinol Metab, 2009; 297(3):E812–E821; doi: 10.1152/ajpendo.00053.2009
4.
AlhammadR, KhunchaiS, TongmuangN, et al.Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state. Oncol Rep, 2020; 44(6):2406–2418; doi: 10.3892/or.2020.7816
5.
ArnerES, HolmgrenA. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 2000; 267(20):6102–6109; doi: 10.1046/j.1432-1327.2000.01701.x
6.
BakkerEY, FujiiM, Krstic-DemonacosM, et al.Protein disulfide isomerase A1associated pathways in the development of stratified breast cancer therapies. Int J Oncol, 2022; 60(2):16; doi: 10.3892/ijo.2022.5306
7.
BechtelTJ, WeerapanaE. From structure to redox: The diverse functional roles of disulfides and implications in disease. Proteomics, 2017; 17(6):10–16; doi: 10.1002/pmic.201600391
8.
BenhamAM. The protein disulfide isomerase family: Key players in health and disease. Antioxid Redox Signal, 2012; 16(8):781–789; doi: 10.1089/ars.2011.4439
9.
Bilches MedinasD, MalikS, Yildiz-BolukbasiE, et al.Mutation in protein disulfide isomerase A3 causes neurodevelopmental defects by disturbing endoplasmic reticulum proteostasis. EMBO J, 2022; 41(2):e105531; doi: 10.15252/embj.2020105531
10.
BjornsdottirHH, RawshaniA, RawshaniA, et al.A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time. Sci Rep, 2020; 10(1):17376; doi: 10.1038/s41598-020-73668-y
11.
BouchalovaP, SommerovaL, PotesilD, et al.Characterization of the AGR2 interactome uncovers new players of protein disulfide isomerase network in cancer cells. Mol Cell Proteomics, 2022; 21(2):100188; doi: 10.1016/j.mcpro.2021.100188
12.
BurikhanovR, ZhaoY, GoswamiA, et al.The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell, 2009; 138(2):377–388; doi: 10.1016/j.cell.2009.05.022
13.
CamargoLL, BabelovaA, MiethA, et al.Endo-PDI is required for TNFalpha-induced angiogenesis. Free Radic Biol Med, 2013; 65:1398–1407; doi: 10.1016/j.freeradbiomed.2013.09.028
14.
CarstensenB, ReadSH, FriisS, et al.Cancer incidence in persons with type 1 diabetes: A five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia, 2016; 59(5):980–988; doi: 10.1007/s00125-016-3884-9
15.
ChangX, XuB, WangL, et al.Investigating a pathogenic role for TXNDC5 in tumors. Int J Oncol, 2013; 43(6):1871–1884; doi: 10.3892/ijo.2013.2123
16.
CharltonHK, WebsterJ, KrugerS, et al.ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling. Biochem Biophys Res Commun, 2010; 392(2):234–239; doi: 10.1016/j.bbrc.2010.01.029
17.
ChawsheenHA, JiangH, YingQ, et al.The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells. J Biol Chem, 2019; 294(22):8991–9006; doi: 10.1074/jbc.RA118.005804
18.
ChawsheenHA, YingQ, JiangH, et al.A critical role of the thioredoxin domain containing protein 5 (TXNDC5) in redox homeostasis and cancer development. Genes Dis, 2018; 5(4):312–322; doi: 10.1016/j.gendis.2018.09.003
19.
ChenIH, ChangFR, WuYC, et al.3,4-Methylenedioxy-beta-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing beta1 integrin function and surface protein disulfide isomerase. Biochimie, 2015; 110:81–92; doi: 10.1016/j.biochi.2015.01.006
20.
ChenTY, YangCY, YangMT, et al.Protein disulfide isomerase a4 promotes lung cancer development via the Stat3 pathway in stromal cells. Clin Transl Med, 2022; 12(2):e606; doi: 10.1002/ctm2.606
21.
ChenYT, JhaoPY, HungCT, et al.Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-beta signaling in kidney fibroblasts. J Clin Invest, 2021; 131(5):e143645; doi: 10.1172/JCI143645
22.
ChevetE, FessartD, DelomF, et al.Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development. Oncogene, 2013; 32(20):2499–2509; doi: 10.1038/onc.2012.346
23.
ChhabraNF, AmendAL, Bastidas-PonceA, et al.A point mutation in the Pdia6 gene results in loss of pancreatic beta-cell identity causing overt diabetes. Mol Metab, 2021; 54:101334; doi: 10.1016/j.molmet.2021.101334
24.
ChoK, ChoS, LeeSO, et al.Redox-regulated peptide transfer from the transporter associated with antigen processing to major histocompatibility complex class I molecules by protein disulfide isomerase. Antioxid Redox Signal, 2011; 15(3):621–633; doi: 10.1089/ars.2010.3756
25.
ChungK, NishiyamaN, WanibuchiH, et al.AGR2 as a potential biomarker of human lung adenocarcinoma. Osaka City Med J, 2012; 58(1):13–24.
26.
ColomboC, PorzioO, LiuM, et al.Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest, 2008; 118(6):2148–2156; doi: 10.1172/JCI33777
27.
CorazzariM, LovatPE, ArmstrongJL, et al.Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: The role of stress proteins ERdj5 and ERp57. Br J Cancer, 2007; 96(7):1062–1071; doi: 10.1038/sj.bjc.6603672
28.
de SenyD, BianchiE, BaiwirD, et al.Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score. Sci Rep, 2020; 10(1):14159; doi: 10.1038/s41598-020-70803-7
29.
Diaz CruzMA, KarlssonS, SzekeresF, et al.Differential expression of protein disulfide-isomerase A3 isoforms, PDIA3 and PDIA3N, in human prostate cancer cell lines representing different stages of prostate cancer. Mol Biol Rep, 2021; 48(3):2429–2436; doi: 10.1007/s11033-021-06277-1
30.
DiMaioMA, KwokS, MontgomeryKD, et al.Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: A combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping. Hum Pathol, 2012; 43(11):1799–1807; doi: 10.1016/j.humpath.2012.03.019
31.
DongA, WodziakD, LoweAW. Epidermal growth factor receptor (EGFR) signaling requires a specific endoplasmic reticulum thioredoxin for the post-translational control of receptor presentation to the cell surface. J Biol Chem, 2015; 290(13):8016–8027; doi: 10.1074/jbc.M114.623207
32.
DuivenvoordenWC, PaschosA, HopmansSN, et al.Endoplasmic reticulum protein ERp46 in renal cell carcinoma. PLoS One, 2014; 9(3):e90389; doi: 10.1371/journal.pone.0090389
33.
ElettoD, ElettoD, DershD, et al.Protein disulfide isomerase A6 controls the decay of IRE1alpha signaling via disulfide-dependent association. Mol Cell, 2014; 53(4):562–576; doi: 10.1016/j.molcel.2014.01.004
34.
EssexDW. Redox control of platelet function. Antioxid Redox Signal, 2009; 11(5):1191–1225; doi: 10.1089/ARS.2008.2322
35.
FanF, ZhangQ, ZhangY, et al.Two protein disulfide isomerase subgroups work synergistically in catalyzing oxidative protein folding. Plant Physiol, 2022; 188(1):241–254; doi: 10.1093/plphys/kiab457
36.
FernandezCJ, GeorgeAS, SubrahmanyanNA, et al.Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World J Methodol, 2021; 11(3):23–45; doi: 10.5662/wjm.v11.i3.23
37.
FerrariDM, SolingHD. The protein disulphide-isomerase family: Unravelling a string of folds. Biochem J, 1999; 339(Pt 1):1–10; doi: 10.1042/bj3390001
38.
FerrariDM, Van NguyenP, KratzinHD, et al.ERp28, a human endoplasmic-reticulum-lumenal protein, is a member of the protein disulfide isomerase family but lacks a CXXC thioredoxin-box motif. Eur J Biochem, 1998; 255(3):570–579; doi: 10.1046/j.1432-1327.1998.2550570.x
GoldbergerRF, EpsteinCJ, AnfinsenCB. Acceleration of reactivation of reduced bovine pancreatic ribonuclease by a microsomal system from rat liver. J Biol Chem, 1963; 238(2):628–635; doi: 10.1016/S0021-9258(18)81309-6
41.
GonzalezV, PalR, NarayanM. The oxidoreductase behavior of protein disulfide isomerase impedes fold maturation of endoplasmic reticulum-processed proteins in the pivotal structure-coupled step of oxidative folding: Implications for subcellular protein trafficking. Biochemistry, 2010; 49(29):6282–6289; doi: 10.1021/bi100753s
42.
GrubbS, GuoL, FisherEA, et al.Protein disulfide isomerases contribute differentially to the endoplasmic reticulum-associated degradation of apolipoprotein B and other substrates. Mol Biol Cell, 2012; 23(4):520–532; doi: 10.1091/mbc.E11-08-0704
43.
HahmE, LiJ, KimK, et al. Extracellular protein disulfide isomerase regulates ligand-binding activity of alphaMbeta2 integrin and neutrophil recruitment during vascular inflammation. Blood, 2013;121(19):3789–3800, S1–S15; doi: 10.1182/blood-2012-11-467985
44.
HatahetF, RuddockLW. Protein disulfide isomerase: A critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal, 2009; 11(11):2807–2850; doi: 10.1089/ars.2009.2466
45.
HigaA, TaoujiS, LhomondS, et al.Endoplasmic reticulum stress-activated transcription factor ATF6alpha requires the disulfide isomerase PDIA5 to modulate chemoresistance. Mol Cell Biol, 2014; 34(10):1839–1849; doi: 10.1128/MCB.01484-13
46.
HopkinsBD, GoncalvesMD, CantleyLC. Insulin-PI3K signalling: An evolutionarily insulated metabolic driver of cancer. Nat Rev Endocrinol, 2020; 16(5):276–283; doi: 10.1038/s41574-020-0329-9
47.
Horna-TerronE, Pradilla-DiesteA, Sanchez-de-DiegoC, et al.TXNDC5, a newly discovered disulfide isomerase with a key role in cell physiology and pathology. Int J Mol Sci, 2014; 15(12):23501–23518; doi: 10.3390/ijms151223501
48.
HudsonDA, GannonSA, ThorpeC. Oxidative protein folding: From thiol-disulfide exchange reactions to the redox poise of the endoplasmic reticulum. Free Radic Biol Med, 2015; 80:171–182; doi: 10.1016/j.freeradbiomed.2014.07.037
49.
HungCT, SuTH, ChenYT, et al.Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFbeta signalling. Gut, 2022; 71(9):1876–1891; doi: 10.1136/gutjnl-2021-325065
50.
InoueT, DoseyA, HerbstmanJF, et al.ERdj5 reductase cooperates with protein disulfide isomerase to promote simian virus 40 endoplasmic reticulum membrane translocation. J Virol, 2015; 89(17):8897–8908; doi: 10.1128/JVI.00941-15
51.
JangI, PottekatA, PoothongJ, et al.PDIA1/P4HB is required for efficient proinsulin maturation and ss cell health in response to diet induced obesity. Elife, 2019; 8:e44528; doi: 10.7554/eLife.44528
52.
JastrzabA, SkrzydlewskaE. Thioredoxin-dependent system. Application of inhibitors. J Enzyme Inhib Med Chem, 2021; 36(1):362–371; doi: 10.1080/14756366.2020.1867121
53.
JinY, SharmaA, BaiS, et al.Risk of type 1 diabetes progression in islet autoantibody-positive children can be further stratified using expression patterns of multiple genes implicated in peripheral blood lymphocyte activation and function. Diabetes, 2014; 63(7):2506–2515; doi: 10.2337/db13-1716
54.
JordanPA, StevensJM, HubbardGP, et al.A role for the thiol isomerase protein ERP5 in platelet function. Blood, 2005; 105(4):1500–1507; doi: 10.1182/blood-2004-02-0608
55.
KemminkJ, DarbyNJ, DijkstraK, et al.The folding catalyst protein disulfide isomerase is constructed of active and inactive thioredoxin modules. Curr Biol, 1997; 7(4):239–245; doi: 10.1016/s0960-9822(06)00119-9
56.
KhannaM, AgrawalN, ChandraR, et al.Targeting unfolded protein response: A new horizon for disease control. Expert Rev Mol Med, 2021; 23:e1; doi: 10.1017/erm.2021.2
57.
KuoTF, HsuSW, HuangSH, et al.Pdia4 regulates beta-cell pathogenesis in diabetes: Molecular mechanism and targeted therapy. EMBO Mol Med, 2021; 13(10):e11668; doi: 10.15252/emmm.201911668
58.
LampropoulouE, LymperopoulouA, CharonisA. Reduced expression of ERp46 under diabetic conditions in beta-cells and the effect of liraglutide. Metabolism, 2016; 65(1):7–15; doi: 10.1016/j.metabol.2015.09.011
59.
LeeE, LeeDH. Emerging roles of protein disulfide isomerase in cancer. BMB Rep, 2017; 50(8):401–410; doi: 10.5483/BMBRep.2017.50.8.107
60.
LeeSO, JinUH, KangJH, et al.The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Mol Cancer Res, 2014; 12(4):527–538; doi: 10.1158/1541-7786.MCR-13-0567
61.
LeeTH, YehCF, LeeYT, et al.Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFbeta signaling through TGFBR1 stabilization. Nat Commun, 2020; 11(1):4254; doi: 10.1038/s41467-020-18047-x
62.
LeitnerBP, SiebelS, AkingbesoteND, et al.Insulin and cancer: A tangled web. Biochem J, 2022; 479(5):583–607; doi: 10.1042/BCJ20210134
63.
LuH, GaoL, LvJ. Circ_0078710 promotes the development of liver cancer by upregulating TXNDC5 via miR-431-5p. Ann Hepatol, 2022; 27(1):100551; doi: 10.1016/j.aohep.2021.100551
64.
MatsuoY, IrieK, KiyonariH, et al.The protective role of the transmembrane thioredoxin-related protein TMX in inflammatory liver injury. Antioxid Redox Signal, 2013; 18(11):1263–1272; doi: 10.1089/ars.2011.4430
65.
MatsusakiM, KanemuraS, KinoshitaM, et al.The protein disulfide isomerase family: From proteostasis to pathogenesis. Biochim Biophys Acta Gen Subj, 2020; 1864(2):129338; doi: 10.1016/j.bbagen.2019.04.003
66.
NaKS, ParkBC, JangM, et al.Protein disulfide isomerase is cleaved by caspase-3 and -7 during apoptosis. Mol Cells, 2007; 24(2):261–267.
67.
OkumuraM, NoiK, InabaK. Visualization of structural dynamics of protein disulfide isomerase enzymes in catalysis of oxidative folding and reductive unfolding. Curr Opin Struct Biol, 2021; 66:49–57; doi: 10.1016/j.sbi.2020.10.004
68.
OkumuraM, NoiK, KanemuraS, et al.Dynamic assembly of protein disulfide isomerase in catalysis of oxidative folding. Nat Chem Biol, 2019; 15(5):499–509; doi: 10.1038/s41589-019-0268-8
69.
PatwardhanRS, SharmaD, SandurSK. Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer. Transl Oncol, 2022; 17:101341; doi: 10.1016/j.tranon.2022.101341
70.
Perez-VargasJ, TeppaE, AmiracheF, et al.A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process. Elife, 2021; 10:e64507; doi: 10.7554/eLife.64507
71.
PopielarskiM, PonamarczukH, StasiakM, et al.The role of protein disulfide isomerase and thiol bonds modifications in activation of integrin subunit alpha11. Biochem Biophys Res Commun, 2018; 495(2):1635–1641; doi: 10.1016/j.bbrc.2017.11.186
72.
PradhanR, YuO, PlattRW, et al.Long-term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom. Diabetes Res Clin Pract, 2022; 185:109229; doi: 10.1016/j.diabres.2022.109229
73.
PrimmTP, WalkerKW, GilbertHF. Facilitated protein aggregation. Effects of calcium on the chaperone and anti-chaperone activity of protein disulfide-isomerase. J Biol Chem, 1996; 271(52):33664–33669; doi: 10.1074/jbc.271.52.33664
74.
PuigA, GilbertHF. Protein disulfide isomerase exhibits chaperone and anti-chaperone activity in the oxidative refolding of lysozyme. J Biol Chem, 1994; 269(10):7764–7771; doi: 10.1016/S0021-9258(17)37352-0
75.
RajpalG, SchuikiI, LiuM, et al.Action of protein disulfide isomerase on proinsulin exit from endoplasmic reticulum of pancreatic beta-cells. J Biol Chem, 2012; 287(1):43–47; doi: 10.1074/jbc.C111.279927
76.
Rey-RenonesC, Baena-DiezJM, Aguilar-PalacioI, et al.Type 2 diabetes mellitus and cancer: Epidemiology, physiopathology and prevention. Biomedicines, 2021; 9(10):1429; doi: 10.3390/biomedicines9101429
77.
RobinsonRM, ReyesL, DuncanRM, et al.Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitor. Eur J Med Chem, 2020; 186:111906; doi: 10.1016/j.ejmech.2019.111906
78.
RosenbergN, Mor-CohenR, SheptovitskyVH, et al.Integrin-mediated cell adhesion requires extracellular disulfide exchange regulated by protein disulfide isomerase. Exp Cell Res, 2019; 381(1):77–85; doi: 10.1016/j.yexcr.2019.04.017
79.
RutledgeAC, QiuW, ZhangR, et al.Role of cysteine-protease CGHC motifs of ER-60, a protein disulfide isomerase, in hepatic apolipoprotein B100 degradation. Arch Biochem Biophys, 2013; 537(1):104–112; doi: 10.1016/j.abb.2013.06.013
80.
RyuJ, ParkSG, LeePY, et al.Dimerization of pro-oncogenic protein Anterior Gradient 2 is required for the interaction with BiP/GRP78. Biochem Biophys Res Commun, 2013; 430(2):610–615; doi: 10.1016/j.bbrc.2012.11.105
81.
SalehR, Sasidharan NairV, MurshedK, et al.Transcriptome of CD8(+) tumor-infiltrating T cells: A link between diabetes and colorectal cancer. Cancer Immunol Immunother, 2021; 70(9):2625–2638; doi: 10.1007/s00262-021-02879-7
82.
SalmansML, ZhaoF, AndersenB. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: A potential drug target and biomarker. Breast Cancer Res, 2013; 15(2):204; doi: 10.1186/bcr3408
83.
SandamalikaWMG, SamaraweeraAV, YangH, et al.A newly discovered teleost disulfide isomerase, thioredoxin domain containing 5 (TXNDC5), from big-belly seahorse (Hippocampus abdominalis): Insights into its molecular and functional properties and immune regulatory functions. Dev Comp Immunol, 2021; 114:103827; doi: 10.1016/j.dci.2020.103827
84.
ScheunerD, Vander MierdeD, SongB, et al.Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat Med, 2005; 11(7):757–764; doi: 10.1038/nm1259
85.
Schorr-LenzAM, AlvesJ, HenckesNA, et al.GnRH immunization alters the expression and distribution of protein disulfide isomerases in the epididymis. Andrology, 2016; 4(5):957–963; doi: 10.1111/andr.12205
86.
SchultenHJ. Pleiotropic effects of metformin on cancer. Int J Mol Sci, 2018; 19(10):2850; doi: 10.3390/ijms19102850
87.
ShinBK, WangH, YimAM, et al.Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem, 2003; 278(9):7607–7616; doi: 10.1074/jbc.M210455200
88.
ShishkinSS, EreminaLS, KovalevLI, et al.AGR2, ERp57/GRP58, and some other human protein disulfide isomerases. Biochem Biokhim, 2013; 78(13):1415–1430; doi: 10.1134/s000629791313004x
89.
SobierajskaK, SkurzynskiS, StasiakM, et al.Protein disulfide isomerase directly interacts with beta-actin Cys374 and regulates cytoskeleton reorganization. J Biol Chem, 2014; 289(9):5758–5773; doi: 10.1074/jbc.M113.479477
90.
StoyJ, EdghillEL, FlanaganSE, et al.Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci U S A, 2007; 104(38):15040–15044; doi: 10.1073/pnas.0707291104
91.
SupabpholS, SeubwaiW, WongkhamS, et al.High glucose: An emerging association between diabetes mellitus and cancer progression. J Mol Med (Berl), 2021; 99(9):1175–1193; doi: 10.1007/s00109-021-02096-w
92.
SwiatkowskaM, SzymanskiJ, PadulaG, et al.Interaction and functional association of protein disulfide isomerase with alphaVbeta3 integrin on endothelial cells. FEBS J, 2008; 275(8):1813–1823; doi: 10.1111/j.1742-4658.2008.06339.x
93.
SyedF, SinghalD, RaedscheldersK, et al. A discovery-based proteomics approach identifies protein disulfide isomerase (PDIA1) as a biomarker of β cell stress in type 1 diabetes. bioRxiv, 2021.12.22.473924; doi: 10.1101/2021.12.22.473924
94.
TakagiH, TakahashiT, MomoseH, et al.Enhancement of the thermostability of subtilisin E by introduction of a disulfide bond engineered on the basis of structural comparison with a thermophilic serine protease. J Biol Chem, 1990; 265(12):6874–6878; doi: 10.1016/S0021-9258(19)39230-0
95.
TanakaT, NakamuraH, NishiyamaA, et al.Redox regulation by thioredoxin superfamily; protection against oxidative stress and aging. Free Radic Res, 2000; 33(6):851–855; doi: 10.1080/10715760000301361
96.
TianG, KoberFX, LewandrowskiU, et al.The catalytic activity of protein-disulfide isomerase requires a conformationally flexible molecule. J Biol Chem, 2008; 283(48):33630–33640; doi: 10.1074/jbc.M806026200
97.
TorpeN, GopalS, BaltaciO, et al. A protein disulfide isomerase controls neuronal migration through regulation of Wnt secretion. Cell Rep, 2019;26(12):3183.e5–3190.e5; doi: 10.1016/j.celrep.2019.02.072
98.
TrivediMV, LaurenceJS, SiahaanTJ. The role of thiols and disulfides on protein stability. Curr Protein Pept Sci, 2009; 10(6):614–625; doi: 10.2174/2F138920309789630534
TuranoC, CoppariS, AltieriF, et al.Proteins of the PDI family: Unpredicted non-ER locations and functions. J Cell Physiol, 2002; 193(2):154–163; doi: 10.1002/jcp.10172
101.
VictorP, SaradaD, RamkumarKM. Crosstalk between endoplasmic reticulum stress and oxidative stress: Focus on protein disulfide isomerase and endoplasmic reticulum oxidase 1. Eur J Pharmacol, 2021; 892:173749; doi: 10.1016/j.ejphar.2020.173749
102.
VigneriR, SciaccaL, VigneriP. Rethinking the Relationship between insulin and cancer. Trends Endocrinol Metab, 2020; 31(8):551–560; doi: 10.1016/j.tem.2020.05.004
103.
WangL, SongG, ChangX, et al.The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway. Oncogene, 2015; 34(36):4735–4745; doi: 10.1038/onc.2014.401
104.
WeichselA, GasdaskaJR, PowisG, et al.Crystal structures of reduced, oxidized, and mutated human thioredoxins: Evidence for a regulatory homodimer. Structure, 1996; 4(6):735–751; doi: 10.1016/s0969-s2126(96)00079-2
105.
WillemsSH, TapeCJ, StanleyPL, et al.Thiol isomerases negatively regulate the cellular shedding activity of ADAM17. Biochem J, 2010; 428(3):439–450; doi: 10.1042/bj20100179
106.
WuZ, ZhangL, LiN, et al.An immunohistochemical study of thioredoxin domain-containing 5 expression in gastric adenocarcinoma. Oncol Lett, 2015; 9(3):1154–1158; doi: 10.3892/ol.2014.2832
107.
XuQ, ZhangJ. Novel strategies for targeting the thioredoxin system for cancer therapy. Expert Opin Drug Discov, 2022; 17(5):437–442; doi: 10.1080/17460441.2022.2045270
108.
XuS, SankarS, NeamatiN. Protein disulfide isomerase: A promising target for cancer therapy. Drug Discov Today, 2014; 19(3):222–240; doi: 10.1016/j.drudis.2013.10.017
109.
YamadaR, CaoX, ButkevichAN, et al.Discovery and preclinical evaluation of a novel class of cytotoxic propynoic acid carbamoyl methyl amides (PACMAs). J Med Chem, 2011; 54(8):2902–2914; doi: 10.1021/jm101655d
110.
YehHC, GolozarA, BrancatiFL. Cancer and Diabetes. In: Diabetes in America, 3rd ed. (Cowie CC, Casagrande SS, Menke A, et al. eds.) Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 29-1–29-21, 2018.
111.
ZanettiM, XianS, DossetM, et al.The unfolded protein response at the tumor-immune interface. Front Immunol, 2022; 13:823157; doi: 10.3389/fimmu.2022.823157
112.
ZangH, LiY, ZhangX, et al.Circ_0000517 contributes to hepatocellular carcinoma progression by upregulating TXNDC5 via sponging miR-1296-5p. Cancer Manag Res, 2020; 12:3457–3468; doi: 10.2147/CMAR.S244024
113.
ZengY, MaW, MaC, et al.Inhibition of TXNDC5 attenuates lipopolysaccharide-induced septic shock by altering inflammatory responses. Lab Invest, 2022; 102(4):422–431; doi: 10.1038/s41374-021-00711-5
114.
ZhangD, PuttiTC. Over-expression of ERp29 attenuates doxorubicin-induced cell apoptosis through up-regulation of Hsp27 in breast cancer cells. Exp Cell Res, 2010; 316(20):3522–3531; doi: 10.1016/j.yexcr.2010.08.014
115.
ZhangD, RichardsonDR. Endoplasmic reticulum protein 29 (ERp29): An emerging role in cancer. Int J Biochem Cell Biol, 2011; 43(1):33–36; doi: 10.1016/j.biocel.2010.09.019
116.
ZhangD, TaiLK, WongLL, et al.Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics, 2005; 4(11):1686–1696; doi: 10.1074/mcp.M400221-MCP200
117.
ZhangL, HouY, LiN, et al.The influence of TXNDC5 gene on gastric cancer cell. J Cancer Res Clin Oncol, 2010; 136(10):1497–1505; doi: 10.1007/s00432-010-0807-x
118.
ZhangP, McGrathB, LiS, et al.The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol, 2002; 22(11):3864–3874; doi: 10.1128/MCB.22.11.3864-3874.2002
119.
ZhengHC, TakahashiH, LiXH, et al.Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Hum Pathol, 2008; 39(7):1042–1049; doi: 10.1016/j.humpath.2007.11.009
